Relieves bronchospasm. ANDA 72151, held by Chartwell Rx. Albuterol Sulfate.
As of Nov 16, 2026, ANDA 72151 (Albuterol Sulfate), held by Chartwell Rx, was first approved by FDA on Mar 23, 1989, with 16 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Albuterol tablets are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 23, 1989 | Original application | Approved | None posted |
| Albuterol SulfateEQ 2MG BASE · tablet;oral | Albuterol Sulfate | Discontinued |
| Albuterol SulfateEQ 4MG BASE · tablet;oral | Albuterol Sulfate | Discontinued |
| Apr 19, 2002 | Supplement 18Manufacturing | Approved | None posted |
| Feb 7, 2002 | Supplement 16Manufacturing | Approved | None posted |
| Dec 13, 2001 | Supplement 17Manufacturing | Approved | None posted |
| Nov 30, 2000 | Supplement 15Manufacturing | Approved | None posted |
| May 5, 1999 | Supplement 14Manufacturing | Approved | None posted |
| Apr 23, 1998 | Supplement 13Labeling | Approved | None posted |
| Nov 5, 1997 | Supplement 12Manufacturing | Approved | None posted |
| Dec 7, 1995 | Supplement 11Manufacturing | Approved | None posted |
| Aug 23, 1994 | Supplement 10Labeling | Approved | None posted |
| Aug 23, 1994 | Supplement 7Manufacturing | Approved | None posted |
| Aug 23, 1994 | Supplement 6Manufacturing | Approved | None posted |
| Aug 23, 1994 | Supplement 5Manufacturing | Approved | None posted |
| Jan 24, 1994 | Supplement 9Manufacturing | Approved | None posted |
| Oct 6, 1993 | Supplement 4Labeling | Approved | None posted |
| May 10, 1991 | Supplement 3Labeling | Approved | None posted |
| Dec 18, 1990 | Supplement 2Labeling | Approved | None posted |
| Mar 23, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters